The American Diabetes Association recommends that all patients receive initial injection training from a healthcare professional and periodic technique review to maintain proper administration skills
You may be suitable for treatment if you: Are aged 18 years or over Have a Body Mass Index (BMI) of 30+ or 27+ with eligible health conditions Are looking for additional support with weight management Have found it difficult to achieve sufficient weight loss through lifestyle changes alone All patients must complete a clinical assessment before treatment can be prescribed
It disrupts sleep, which creates its own separate set of weight loss problems
Kashima Y, Miki T, Shibasaki T et al (2001) Critical role of cAMP-GEFIIRim2 complex in incretin-potentiated insulin secretion
Label every vial with compound name, concentration, and reconstitution date
Bremelanotide PT-141 is a novel treatment option for sexual dysfunction and can provide relief to those suffering from low libido or difficulties in achieving or sustaining sexual arousal
